SINOVAC BIOTECH LTD Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
SINOVAC BIOTECH LTD (SVA) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $1.13 billion as of 2023-12-31, per its 20-F filed 2026-04-30.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-04-30
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $1.13B.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $3.89B.
- 2021-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $11.62B.
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $1.05B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2023-12-31 | $1.13B 20-F · filed 2026-04-30 |
| 2022-12-31 | $3.89B 20-F · filed 2026-04-30 |
| 2021-12-31 | $11.62B 20-F · filed 2026-04-30 |
| 2020-12-31 | $1.05B 20-F · filed 2026-04-30 |